Cargando…

Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus

A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID‐19.

Detalles Bibliográficos
Autores principales: Frankel, Arthur E., Yip, Wai C., Naik, Eknath, Hasselbalch, Hans C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190516/
https://www.ncbi.nlm.nih.gov/pubmed/34136234
http://dx.doi.org/10.1002/ccr3.4218
_version_ 1783705700567875584
author Frankel, Arthur E.
Yip, Wai C.
Naik, Eknath
Hasselbalch, Hans C.
author_facet Frankel, Arthur E.
Yip, Wai C.
Naik, Eknath
Hasselbalch, Hans C.
author_sort Frankel, Arthur E.
collection PubMed
description A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID‐19.
format Online
Article
Text
id pubmed-8190516
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81905162021-06-15 Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus Frankel, Arthur E. Yip, Wai C. Naik, Eknath Hasselbalch, Hans C. Clin Case Rep Case Reports A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID‐19. John Wiley and Sons Inc. 2021-06-09 /pmc/articles/PMC8190516/ /pubmed/34136234 http://dx.doi.org/10.1002/ccr3.4218 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Frankel, Arthur E.
Yip, Wai C.
Naik, Eknath
Hasselbalch, Hans C.
Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
title Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
title_full Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
title_fullStr Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
title_full_unstemmed Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
title_short Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
title_sort response to pegylated interferon in a covid‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190516/
https://www.ncbi.nlm.nih.gov/pubmed/34136234
http://dx.doi.org/10.1002/ccr3.4218
work_keys_str_mv AT frankelarthure responsetopegylatedinterferoninacovid19positivemalewithmetastaticjejunalneuroendocrinetumortreatedwitheverolimus
AT yipwaic responsetopegylatedinterferoninacovid19positivemalewithmetastaticjejunalneuroendocrinetumortreatedwitheverolimus
AT naikeknath responsetopegylatedinterferoninacovid19positivemalewithmetastaticjejunalneuroendocrinetumortreatedwitheverolimus
AT hasselbalchhansc responsetopegylatedinterferoninacovid19positivemalewithmetastaticjejunalneuroendocrinetumortreatedwitheverolimus